Table 2.

Tumor characteristics.

Tumor (N = 25)	Pathology stage (TNM7*)	Tumor differentiation	PDL-1 TC (%)	PDL-1 IC (IC0–4**)	Biopsy weight (mg)
1	T2bN0M0	Adeno	0	IC1	1780
2	T2bN0M0	Squamous	30	IC2	1075
3	T2a N1M0	NSCLC NOS	40	IC1	89
4	T0-1aN0M0	NSCLC NOS	NA	NA	120
5	T2bN1M0	NSCLC NOS	90	IC2	560
6	T1aN0M0	NSCLC NOS	60	IC3	550
7	T2bN0M0	Adeno	0	IC0	1960
8	T2aN2M1a	Squamous	0	IC0	1640
9	T2bN0M0	Adeno	0	IC3	23
10	T1aN1M0	Adeno	0	IC3	182
11	T2aN0M0	Adeno	95	IC2	800
12	T2bN1M0	Adeno	0	IC1	1460
13	T1aN0M0	Adeno	30	IC2	268
14	T1bN0M0	Adeno	2	IC1	221
15	T1bN0M0	Adeno	0	IC0	570
16	T2N1M0	Squamous	0	IC1	310
17	T2aN0M0	Squamous	90	IC2	5770
18	T2aN0M0	Adeno	1	IC2	600
19	T2aN0M0	Squamous	0	IC2	2550
20	T4N0M0	Adeno	0	IC1	9590
21	T1cN0M0	Adeno	90	IC2	610
22	T3N2M0	Adeno	NA	NA	1850
23	excluded	-	-	-	-
24	excluded	-	-	-	-
25	T1cN0M0	Adeno	0	IC3	290

*American Joint committee on Cancer: Lung Cancer Staging, 7^th edition, 2009

**PDL-1 Immune Cell score 0-4

TC = Tumor Cells; IC = Immune Cells; NA = Not Assessed